Literature DB >> 22048257

Pancreatic cancer stem cell biology and its therapeutic implications.

Filip Bednar1, Diane M Simeone.   

Abstract

Pancreatic cancer remains one of the most difficult malignancies to treat. Significant developments in our understanding of pancreatic cancer biology have occurred over the past decade. One of the key advances has been the formulation of the cancer stem cell model of tumor growth and subsequent experimental proof of pancreatic cancer stem cell existence. Cancer stem cells contribute to pancreatic tumor growth and progression and are at least partially responsible for the relative resistance of the tumor to systemic chemotherapy and radiation. Significant questions remain about how the mutational profile of the tumor, the tumor microenvironment, and normal pancreatic developmental pathways contribute to pancreatic cancer stem cell biology. Answers to these questions will likely yield new therapeutic approaches for this deadly disease.

Entities:  

Mesh:

Year:  2011        PMID: 22048257     DOI: 10.1007/s00535-011-0494-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  67 in total

1.  Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

Authors:  Marina Lesina; Magdalena U Kurkowski; Katharina Ludes; Stefan Rose-John; Matthias Treiber; Günter Klöppel; Akihiko Yoshimura; Wolfgang Reindl; Bence Sipos; Shizuo Akira; Roland M Schmid; Hana Algül
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

2.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer.

Authors:  Peter J Campbell; Shinichi Yachida; Laura J Mudie; Philip J Stephens; Erin D Pleasance; Lucy A Stebbings; Laura A Morsberger; Calli Latimer; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena A Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Constance A Griffin; John Burton; Harold Swerdlow; Michael A Quail; Michael R Stratton; Christine Iacobuzio-Donahue; P Andrew Futreal
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

3.  Eyes wide open: a critical review of sphere-formation as an assay for stem cells.

Authors:  Erika Pastrana; Violeta Silva-Vargas; Fiona Doetsch
Journal:  Cell Stem Cell       Date:  2011-05-06       Impact factor: 24.633

4.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

5.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

6.  Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization.

Authors:  Lidong Wang; David G Heidt; Cheong J Lee; Huibin Yang; Craig D Logsdon; Lizhi Zhang; Eric R Fearon; Mats Ljungman; Diane M Simeone
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

7.  A paracrine requirement for hedgehog signalling in cancer.

Authors:  Robert L Yauch; Stephen E Gould; Suzie J Scales; Tracy Tang; Hua Tian; Christina P Ahn; Derek Marshall; Ling Fu; Thomas Januario; Dara Kallop; Michelle Nannini-Pepe; Karen Kotkow; James C Marsters; Lee L Rubin; Frederic J de Sauvage
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

8.  Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.

Authors:  Mei Zhang; Fariba Behbod; Rachel L Atkinson; Melissa D Landis; Frances Kittrell; David Edwards; Daniel Medina; Anna Tsimelzon; Susan Hilsenbeck; Jeffrey E Green; Aleksandra M Michalowska; Jeffrey M Rosen
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

9.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

10.  Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy.

Authors:  Scott J Dylla; Lucia Beviglia; In-Kyung Park; Cecile Chartier; Janak Raval; Lucy Ngan; Kellie Pickell; Jorge Aguilar; Sasha Lazetic; Stephanie Smith-Berdan; Michael F Clarke; Tim Hoey; John Lewicki; Austin L Gurney
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  18 in total

1.  Association between CLPTM1L-TERT rs401681 polymorphism and risk of pancreatic cancer: a meta-analysis.

Authors:  Cheng-Li Liu; Xiao-Xia Zang; Cheng Wang; Ya-Lin Kong; Hui Zhang; Hong-Yi Zhang
Journal:  Clin Exp Med       Date:  2014-10-05       Impact factor: 3.984

2.  Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice.

Authors:  Yoko Matsuda; Hisashi Yoshimura; Junji Ueda; Zenya Naito; Murray Korc; Toshiyuki Ishiwata
Journal:  Am J Pathol       Date:  2014-01-09       Impact factor: 4.307

3.  Pancreatic cancer: translational research aspects and clinical implications.

Authors:  Daniel Ansari; Bi-Cheng Chen; Lei Dong; Meng-Tao Zhou; Roland Andersson
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

4.  Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis.

Authors:  Zhe Huang; Fang Liu
Journal:  Tumour Biol       Date:  2014-05-01

5.  Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population.

Authors:  Lei Zhao; Ying-Xue Wang; Mian Xi; Shi-Liang Liu; Peng Zhang; Li-Ling Luo; Meng-Zhong Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

6.  Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.

Authors:  Vindhya Palagani; Mona El Khatib; Uta Kossatz; Przemyslaw Bozko; Martin R Müller; Michael P Manns; Till Krech; Nisar P Malek; Ruben R Plentz
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

7.  CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis.

Authors:  Ji-Cong Gui; Wei-Li Yan; Xing-Dang Liu
Journal:  Clin Exp Med       Date:  2013-03-03       Impact factor: 3.984

Review 8.  Inflammation and pancreatic cancer: disease promoter and new therapeutic target.

Authors:  Shin Hamada; Atsushi Masamune; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2013-11-30       Impact factor: 7.527

9.  Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer.

Authors:  Xueyan Li; Xiaozhong Guo; Hongyu Li; Hao Lin; Yingwei Sun
Journal:  Tumour Biol       Date:  2014-02-09

Review 10.  Orchestration of hepatocellular carcinoma development by diverse liver cancer stem cells.

Authors:  Taro Yamashita; Shuichi Kaneko
Journal:  J Gastroenterol       Date:  2014-03-20       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.